Covance Not Cooling...
Health Care: Drugs
Sanofi (SNY: NYSE)
$54.50 0.29 | 0.54%
05/17/13 - 04:00 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 54.50 |
| 52 Week High | 55.77 |
| 52 Week Low | 33.03 |
| Avg. Daily Vol. (Mil) | 2.58 |
| Beta (3 year) | 1.07 |
| Share Related Items | |
| Mkt Cap (Mil) | 146,160.15 |
| Shares Out (Mil) | 2,681.84 |
| Float (Mil) | 0.00 |
| Dividend Information | |
| Yield % | 2.40 |
| Annual Dividend | 1.30 |
| Payout Ratio | 93.00 |
| Financial Strength | |
| Quick Ratio | n.a. |
| Current Ratio | n.a. |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | n.a. |
| Valuation Ratios | |
| Price Earnings | 30.10 |
| Price/Sales | 4.31 |
| Price/Book | 0.00 |
| Price/Cash Flow | 12.20 |
| Per Share Data | |
| Earnings | 1.81 |
| Sales | 12.65 |
| Book Value | 0.00 |
| Cash Flow | 4.46 |
| Business Summary | |
|---|---|
| Sanofi is a healthcare company focused on patient needs and engaged in the research, development, manufacture and marketing of healthcare products. The Company also discovers, develops and distributes therapeutic solutions. | |
| General Information | |
| 54, Rue La Botie
Paris, 75008 |
|
| www.sanofi-aventis.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 111974 | |
| CEO: Christopher Viehbacher | |
| Short Interest | |
| Current Month (Mil) | 3.06 |
| Previous Month (Mil) | 2.70 |
| Short Interest Ratio (Days) | 1.00 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | 0.00 |
| Return on Investments | n.a. |
| Profitability | |
| Gross Margin | 69.20 |
| EBIT Margin | -7.90 |
| Profit Margin | 3.90 |
Portfolios with SNY
- Portfolio NameUser Type
- ProWarren Buffett
- ContributorTechnical Setups for the We...
- ContributorStocks Rising On Unusual Vo...
- ProKen Fisher - Fisher Investm...
- ContributorHigh Volume Technicals for ...
- ContributorRocket Stocks for the Week ...
- Contributor9 Stocks to Buy for a Europ...
- ContributorDrugs Facing FDA Approval i...
- Contributor7 Big-Pharma Stocks With Un...
- UserLong Term Stock Picks
Latest SNY Headlines from TheStreet
- Declines From Sanofi (SNY) Drive Down Drugs Industry 04.17.13 | 06:04 pm
- Sanofi Rises On Unusually High Volume (SNY) 04.15.13 | 01:04 pm
- 5 Stocks Pulling The Drugs Industry Downward 04.12.13 | 01:04 pm
- Sanofi Stock Hits New 52-Week High (SNY) 04.10.13 | 12:04 pm
- Sanofi (SNY): Drugs' Featured Champion Of The Day 04.09.13 | 05:04 pm
- Sanofi Reaches New 52-Week High (SNY) 03.28.13 | 11:03 am
- Biogen Wins FDA Approval of MS Pill 03.27.13 | 03:03 pm
- 4 Stocks Dragging The Drugs Industry Downward 03.27.13 | 01:03 pm
- 5 Trades Getting Ready to Pop This Week 03.26.13 | 11:03 am
- Sanofi (SNY): Drugs' Featured Daily Laggard 03.21.13 | 05:03 pm
Press Releases for SNY
- Football Legend Jerome Bettis & Sanofi US Tackle Anaphylaxis During National Asthma And Allergy Awareness Month - PR Newswire 05.16.13 | 08:05 am
- New Gold Bond® No Mess Powder Spray Introduced By Sanofi's Chattem - PR Newswire 05.06.13 | 03:05 pm
- Sanofi US And Actress Elizabeth Perkins Premiere Documentary -- Diabetes Co-Stars Presents "Strength In Numbers" - PR Newswire 05.06.13 | 08:05 am
- NextBio Announces Translational Medicine Partnership With Sanofi - PR Newswire 04.30.13 | 08:04 am
- U.S. FDA Grants Fast-Track Designation To Sanofi Pasteur And KaloBios' Novel Biologic Candidate For Pseudomonas Aeruginosa - PR Newswire 04.23.13 | 08:04 am
- New Allegra® Anti-Itch Cream Introduced By Sanofi's Chattem - PR Newswire 04.11.13 | 08:04 am
- Basketball Legend Lisa Leslie Teams Up With Allegra® To Help Families Enjoy Outdoor Workouts This Allergy Season - PR Newswire 03.28.13 | 10:03 am
- Sanofi And Transgene Announce Innovative Long-Term Collaboration For The Production Of Immunotherapy Treatments - Business Wire 03.25.13 | 02:03 am
- Genzyme Receives Positive CHMP Opinion In The European Union For Once-daily, Oral AUBAGIO® To Treat Relapsing-Remitting Multiple Sclerosis - Business Wire 03.22.13 | 08:03 am
- Effect Of Genzyme’s LEMTRADA™ Maintained In Patients Beyond Two-Year Pivotal MS Studies - Business Wire 03.21.13 | 03:03 pm
Partner Headlines for SNY
- Sanofi (SNY) Ex-Dividend Date Scheduled for May 06, 2013 - NASDAQ 05.03.13 | 01:05 pm
- Ampio Pharma Initiates Phase III, Investors Extend Momentum - Seeking Alpha 05.03.13 | 09:05 am
- Weak Data Hamstring Stocks; Regeneron Pharmaceuticals Soars - Investor's Business Daily 05.01.13 | 12:05 pm
- Regeneron's Flagship Drug Treats Blindness In Seniors - Investor's Business Daily 04.11.13 | 05:04 pm
- 10 Sharp Healthcare Dogs Diagnose 7.4% To 62.1% Gains In March - Seeking Alpha 04.01.13 | 09:04 am
- 5 Dividends Stocks From Billionaire Ken Fisher - Seeking Alpha 03.28.13 | 09:03 am
- Biogen MS Drug Approved; No 'Black Box' Label - Investor's Business Daily 03.27.13 | 06:03 pm
- Moves in Smaller Health Care Stocks (ANAC, HALO, PBYI, QCOR) - Benzinga 03.23.13 | 11:03 am
- Top 9 March Healthcare Dogs Mark 3.4% To 28.7% Gains - Seeking Alpha 03.23.13 | 04:03 am
- Celgene, Regeneron Get Some Favorable News - Investor's Business Daily 02.13.13 | 06:02 pm
